Scientists used to think human evolution mostly stopped tens of thousands of years ago, but new DNA research shows we've actually been adapting in surprising ways much more recently—like, within the last few thousand years. Turns out our genes have been quietly tweaking things like disease resistance and digestion right up through the agricultural revolution and beyond.

What This Mean: This flips the script on how we understand our own biology. If humans are still evolving in measurable ways during recorded history, it suggests our relationship with things like farming, cities, or even modern medicine might be shaping us at a genetic level. That’s wild to think about—and could change how we study everything from nutrition to disease prevention.

Genetic testing pioneer 23andMe, which filed for bankruptcy after a rough year of dwindling demand and a major data leak, is being scooped up by biotech giant Regeneron for $256 million. The deal doesn’t include 23andMe’s telehealth arm, Lemonaid Health, which is getting axed. Regeneron is promising to protect the genetic data of 15 million users—a key concern after last year’s breach—but the future of the once-popular DNA service remains uncertain under new ownership.

What This Mean: This isn’t just another business deal—it’s a turning point for a company that brought DNA testing into the mainstream. 23andMe’s stumble highlights how tricky it is to monetize personal genetics while keeping data safe. For Regeneron, it’s a bargain buy with potential research gold (those 15 million genetic profiles could fuel drug discovery), but also a PR tightrope. If you’ve ever spit in a 23andMe tube, you’ll want to keep an eye on how your data’s handled under the new regime.